Clinical Trial Update: Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated a combination of temozolomide, thalidomide, and lomustine in patients with unresectable stage III or IV melanoma, including uveal and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Uveal Melanoma

Drugs mentioned

• CeeNU (lomustine)
• Temodar (Temozolomide)
• Thalomid (thalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Status: COMPLETED